What You Should Know
– Ultrahuman, the global leader in wearable health technology, has partnered with Click Therapeutics to develop the Migraine PowerPlug. This first-of-its-kind tool integrates the proprietary technology behind Click’s CT-132—the first and…
Continue Reading
I’ve been a follower of prescription digital therapeutics for years. I have watched with great sadness as companies have come and gone without getting the traction their products needed to help broad groups of…
Continue Reading
Digital therapeutic company Click Therapeutics was granted FDA marketing authorization for its prescription digital therapeutic for the preventive treatment of episodic migraines.The de novo classification is for the company’s CT-132 offering, which it received…
Continue Reading
What You Should Know:
– Click Therapeutics, Inc. (“Click”), a leader in the rapidly evolving field of prescription medical treatments, encompassing both prescription digital therapeutics (PDTs) and software-enhanced drug™ therapies has received FDA marketing authorization…
Continue Reading
What You Should Know:
– Dassault Systèmes has announced a strategic investment in Click Therapeutics, a pioneering company in prescription digital therapeutics (PDTs) and software-enhanced (SE) drug therapies. This investment signifies Dassault Systèmes’ commitment to…
Continue Reading
When the FDA approves a drug, passing that regulatory bar of safety and efficacy puts it on the path toward likely reimbursement by government and commercial payers. The same has not been true for…
Continue Reading
